These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17425750)

  • 1. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.
    Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K
    Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ; Ynares C; Dummer JS
    Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in renal transplant recipients: the evidence for prophylaxis.
    Currie AC; Knight SR; Morris PJ
    Transplantation; 2010 Oct; 90(7):695-704. PubMed ID: 20647975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of isoniazid chemoprophylaxis in renal transplant recipients.
    Naqvi R; Naqvi A; Akhtar S; Ahmed E; Noor H; Saeed T; Akhtar F; Rizvi A
    Nephrol Dial Transplant; 2010 Feb; 25(2):634-7. PubMed ID: 19783599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.
    Singh N; Wagener MM; Gayowski T
    Transplantation; 2002 Sep; 74(6):892-5. PubMed ID: 12364876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
    Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of isoniazid prophylaxis against tuberculosis in Chinese renal transplant recipients.
    Lui SL; Li FK; Choy BY; Chan TM; Lo WK; Lai KN
    Transpl Infect Dis; 2004 Mar; 6(1):55-6. PubMed ID: 15225230
    [No Abstract]   [Full Text] [Related]  

  • 8. Is isoniazid safe for liver transplant candidates with latent tuberculosis?
    Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY
    Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Jahng AW; Tran T; Bui L; Joyner JL
    Transplantation; 2007 Jun; 83(12):1557-62. PubMed ID: 17589337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of isoniazid prophylaxis in renal allograft recipients.
    Naqvi R; Akhtar S; Noor H; Saeed T; Bhatti S; Sheikh R; Ahmed E; Akhtar F; Naqvi A; Rizvi A
    Transplant Proc; 2006 Sep; 38(7):2057-8. PubMed ID: 16979998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis.
    Al-Mukhaini SM; Al-Eid H; Alduraibi F; Hakami HI; Talhi HA; Shoukri M; Ahmed AM; Ahmed Y; Alrajhi AA
    Ann Saudi Med; 2017; 37(2):138-143. PubMed ID: 28377543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis in liver transplant recipients: prophylaxis in an endemic area.
    Agoglia L; Balbi E; Halpern M; Roma J; Carius L; Martinho JM; Moreira LP
    Transplant Proc; 2011; 43(1):199-202. PubMed ID: 21335188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area.
    Moon HH; Park SY; Kim JM; Park JB; Kwon CHD; Peck KR; Kim SJ; Lee SK; Joh JW
    Ann Transplant; 2017 Jun; 22():338-345. PubMed ID: 28579606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center.
    Olithselvan A; Rajagopala S; Vij M; Shanmugam V; Shanmugam N; Rela M
    Liver Transpl; 2014 Aug; 20(8):960-6. PubMed ID: 24789170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis in renal transplant recipients: a Brazilian center registry.
    Guida JP; Bignotto Rosane D; Urbini-Santos C; Alves-Filho G; Ribeiro Resende M; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):883-4. PubMed ID: 19376379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation.
    Chan AC; Lo CM; Ng KK; Chan SC; Fan ST
    Liver Int; 2007 Feb; 27(1):81-5. PubMed ID: 17241385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis infection in renal transplant recipients.
    Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
    Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey.
    Tavil B; Gulhan B; Ozcelik U; Cetin M; Tezcan I; Tuncer M; Uckan D
    Pediatr Transplant; 2007 Jun; 11(4):414-8. PubMed ID: 17493222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.